Top compounds associated with response to RNF180


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.2 0.0001
mRNA KIN001-236 GDSC1000 pan-cancer AAC 0.11 0.0004
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA Vorinostat GDSC1000 pan-cancer AAC -0.09 0.003
mRNA IC-87114 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.003
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.005
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.094 0.005
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.1 0.006
mRNA Doxorubicin gCSI pan-cancer AAC -0.14 0.007
Download CSV